Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma.
Julia A Woolgar
https://pubmed.ncbi.nlm.nih.gov/16150633/Actively Recruiting
Led by Kolhapur Cancer Centre - Cancer Centers of America · Updated on 2026-08-04
267
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to compare two surgical approaches for adults with clinically node-negative oral squamous cell carcinoma OSCC undergoing curative surgery. It evaluates whether selective neck dissection involving lymph node levels I-III is as effective as including level IV in controlling cancer, while also assessing the impact on surgical complications, shoulder function, and quality of life. The trial addresses important questions about cancer control and postoperative recovery in this patient group. Participants will be randomly assigned to undergo selective neck dissection of either levels I-III or levels I-IV. Surgery involves removal of lymphatic tissue in the neck while preserving key nerves and muscles unless involvement by the tumor requires otherwise. After surgery, patients receive standard postoperative care including radiotherapy or chemoradiotherapy if indicated. The study includes regular follow-up visits for clinical examination and cancer surveillance. Throughout the study, participants will be assessed on regional recurrence-free survival up to three years after surgery. Researchers will also monitor overall survival, disease-free survival, patterns of nodal failure, and rates of hidden nodal metastasis. Functional outcomes such as shoulder function and neck impairment, as well as postoperative complications and quality of life, will be evaluated at multiple time points using validated questionnaires. This comprehensive follow-up aims to capture both cancer control and patient well-being over time.
CONDITIONS
Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread
M
Maroti B Wadewale, MDS, FHNO
P
Parag J Watve, MS, FHNS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kolhapur Cancer Centre - Cancer Centers of America
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single surgery with postoperative follow-up up to 3 years
Participants undergo surgery to remove the oral tumor and receive selective neck dissection of either levels I-III or levels I-IV. Postoperative care including radiotherapy or chemoradiotherapy is provided if needed.
Scheduled follow-up visits for clinical exams and assessments
Duration - Up to 3 years after surgery
Participants attend regular visits for clinical examinations, imaging, and functional assessments to monitor cancer recurrence, shoulder function, sensory function, complications, and quality of life.
Multiple visits at specified intervals over 3 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Julia A Woolgar
https://pubmed.ncbi.nlm.nih.gov/16150633/Rodney J Taylor, Judith C Chepeha, Theodoros N Teknos...
https://pubmed.ncbi.nlm.nih.gov/11784253/Anil K D'Cruz, Richa Vaish, Neeti Kapre...
https://pubmed.ncbi.nlm.nih.gov/26027881/Gouri H Pantvaidya, Pooja Pal, Abhishek D Vaidya...
https://pubmed.ncbi.nlm.nih.gov/23996343/Jatin P Shah, Ziv Gil
https://pubmed.ncbi.nlm.nih.gov/18674952/Johnny Cappiello, Cesare Piazza, Marco Giudice...
https://pubmed.ncbi.nlm.nih.gov/15689746/Kolhapur Cancer Centre - Cancer Centers of America
Lead Sponsor